Optimal sequence and second-line systemic treatment of patients with ras wild-type metastatic colorectal cancer: A meta-analysis

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Although several sequential therapy options are available for treating patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC), the optimal sequence of these therapies is not well established. A systematic review and meta-analysis of 13 randomized controlled trials and 4 observational studies were performed, resulting from a search of the Cochrane Library, PubMed, and Embase databases. Overall survival (OS) did not differ significantly in patients with RAS-WT failure who were administered a second-line regimen of changed chemotherapy (CT) plus antiepidermal growth factor receptor (EGFR) versus only changed CT, changed CT plus bevacizumab versus changed CT plus anti-EGFR, or changed CT versus maintaining CT plus anti-EGFR after first-line therapy with CT, plus bevacizumab. However, OS was significantly different with a secondline regimen that included changed CT plus bevacizumab, versus only changing CT. Analysis of first-line therapy with CT plus anti-EGFR for treatment of RAS-WT mCRC indicated that second-line therapy of changed CT plus an anti-EGFR agent resulted in better outcomes than changing CT without targeted agents. The pooled data study demonstrated that the optimal choice of second-line treatment for improved OS was an altered CT regimen with retention of bevacizumab after first-line bevacizumab failure. The best sequence for first-to-second-line therapy of patients with RAS-WT mCRC was cetuximab-based therapy, followed by a bevacizumab-based regimen.

Cite

CITATION STYLE

APA

Wu, C. C., Hsu, C. W., Hsieh, M. C., Wang, J. H., Chang, M. C., Yang, C. S., & Su, Y. C. (2021). Optimal sequence and second-line systemic treatment of patients with ras wild-type metastatic colorectal cancer: A meta-analysis. Journal of Clinical Medicine, 10(21). https://doi.org/10.3390/jcm10215166

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free